Research programme: HIV vaccine - Novavax/US Universities
Alternative Names: HIV VLP vaccine - NovavaxLatest Information Update: 02 May 2012
At a glance
- Originator Duke University; Emory University; Harvard Medical School; Novavax; University of Alabama
- Developer Novavax
- Class AIDS vaccines; Virus-like particle vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported HIV infections
Most Recent Events
- 02 May 2012 No development reported - Preclinical for HIV infections in USA (unspecified route)
- 19 Dec 2008 Preclinical development is ongoing
- 22 Jan 2007 Preclinical development is ongoing